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Abstract
Background: Adult onset autoimmune enteropathy (AIE) is a rare condition characterized by diarrhea refractory to
dietary therapy diagnosed in patients with evidence of autoimmune conditions. Auto-antibodies to gut epithelial
cells and other tissues are commonly demonstrated. Despite increasing awareness, the pathogenesis, histologic,
immunologic and clinical features of AIE remain uncertain. There remains controversy regarding the diagnostic
criteria, the frequency and types of auto-antibodies and associated autoimmune conditions, and the extent and
types of histologic and immunologic abnormalities. CD4+ T-cells are thought to at least responsible for this
condition; whether other cell types, including B- and other T-cell subsets are involved, are uncertain. We present a
unique case of AIE associated with a CD8+CD7- lymphocytosis and review the literature to characterize the
histologic and immunologic abnormalities, and the autoantibodies and autoimmune conditions associated with
AIE.
Case Presentation: We present a case of immune mediated enteropathy distinguished by the CD8+CD7- intra-
epithelial and lamina propria lymphocytosis. Twenty-nine cases of AIE have been reported. The majority of patients
had auto-antibodies (typically anti-enterocyte), preferential small bowel involvement, and predominately CD3+ CD4
+ infiltrates. Common therapies included steroids or immuno-suppressive agents and clinical response with
associated with histologic improvement.
Conclusions: AIE is most often characterized (1) IgG subclass anti-epithelial cell antibodies, (2) preferential small
bowel involvement, and (3) CD3+ alphabeta TCR+ infiltrates; there is insufficient evidence to conclude CD4+ T-cells
are solely responsible in all cases of AIE.
Background
Immune enteropathies are heterogeneous group of rare
conditions characterized by intractable diarrhea, damage
to intestinal epithelia and constituent cells, and villous
atrophy. These enteropathies may be associated with
primary immune deficiencies (PIDs) such as the
immune dysregulation, polyendocrinopathy, enteropathy,
X-linked (IPEX) syndrome, common variable immune
deficiency and selective IgA deficiency, or may occur in
patients with auto-immune phenomena in the absence
of PIDs where it is termed auto-immune enteropathy
(AIE) [1].
Typically, the diagnosis of immune mediated entero-
pathy in the setting of PIDs is clear from the clinical
features and a pre-existing diagnosis of PID. In contrast,
AIE may be diagnosed in patients with no evidence of
PIDs, intractable diarrhea refractory to exclusion diets,
and no evidence of celiac disease [1].
Cumulatively, immune enteropathies, including AIE,
have an unclear pathogenesis. They are all thought to be
mediated by immune phenomena, either through direct
damage to gut epithelial cells by auto-reactive cells
(IPEX) or auto-antibodies (AIE), or from a propensity
for bowel infections (IgA deficiency). However, the exact
cell types causing damage and the mechanisms of dis-
ease remain unclear in many of these conditions.
Herein, we report a patient with an immune mediated
enteropathy distinguished from previously reported
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+ CD7
- IEL in the absence of a
PID. We also review the literature to characterize the
histologic and immunophenotyic features of AIE, which
our patient’s enteropathy most closely resembles.
Case Presentation
The patient was a 28 year old Asian Indian female of
non-consanguineous parents who presented with a 3
year history of non-bloody diarrhea with abdominal
cramping. Past medical history was significant for hepa-
titis A. She denied alcohol or tobacco use, had no
chronic medical conditions, was not on any medications
including gut irritants such as aspirin/non-steroidials
and did not have a history of travel prior to onset of
symptoms. Her last travel was to India one year prior to
presentation, but she did not report any alleviation or
exacerbation of her symptos with the travel/dietary/
environmental change. She weighed 81 pounds at pre-
sentation. Stool cultures were negative for pathogens.
Basic labs, including the erythrocyte sedimentation rate
and C-reactive protein were normal, but liver function
tests (LFTs) were elevated (Table 1). Abdominal com-
puted tomography (CT) revealed hepatic hypodensities
and mesenteric adenopathy. Serology was negative for
anti-nuclear (ANA) and anti-smooth muscle antibodies
as well as antibodies for cytosolic anti-neutrophil cyto-
plasm (cANCA), liver-kidney microsomes, liver cytosolic
and soluble liver-pancreas antigen. However, pANCA
was positive (titer: > 1:20) and she had hyper-gamma-
globulinemia (IgG: 2358 (630-1580 mg/dl), IgA: 578
(100-400 mg/dl), IgM: 134 (37-247 mg/dl). Serum ceru-
loplasmin was normal, and serology for hepatitis B and
C were negative. Serum B12, folate and hematocrit were
normal.
Histologic examination of intestinal mucosa demon-
strated chronic inflammation with duodenal intraepithe-
lial cell lymphocytosis (IEL) (Table 1) (Figure 1). Celiac
disease and tropical sprue were therefore considered
based on the clinical features and IEL. However, tissue
transglutaminase (TTG) IgA was normal (5.3, reference:
< 7.0 AU), as were anti-enterocyte antibodies (only IgA
tested) (both measured by enzyme linked immuno-
absorbant assay of serum). Indirect immunofluorescence
on human intestinal tissue samples was not performed.
The patient refused liver biopsy, but permitted CT
guided biopsies of the enlarged retroperitoneal and peri-
portal nodes; histologic analysis only demonstrated nor-
mal stroma. She was diagnosed with auto-immune
hepatitis (AIH) based on her revised original Interna-
tional AIH group score of 12 (indicating probable AIH
by criteria)[2].
Over the next 21 months, she continued to have diar-
rhea despite dietary exclusion therapy, and elevated
LFTs (Table 1). Because serum folate and B12 remained
withing normal limits for the duration of her care, she
was not treated with these agents. She did develop a
mild iron deficiency anemia, but never required blood
transfusions. Endoscopy 15 months after presentation
demonstrated progression with grossly friable duodenal
mucosa. There was marked IEL with a CD8
+ T-cell sub-
set without evidence of enteropathy type T-cell lym-
phoma (Figure 2). Flow cytometry revealed a nearly
100% T-cell preponderance, the majority of which were
a polyclonal ab T-cell receptor (TCR)
+ CD8
+ CD7
- sub-
set (Table 1: 15 months). Clonality was assessed by poly-
merase chain reaction of TCR chains. The minority of
IELs were CD4
+ and CD8
+ CD7
+ subsets; there were
normal numbers of intra-epithelial gδ T-cells and rare
Table 1 Liver function test and histologic features pre- and post-prednisone
Pre-prednisone Post-prednisone
Presentation 15 months 21 months 26 months
Liver Function Tests
AST (U/L) 107 43 41 65
ALT (U/L) 95 46 97 82
ALP (U/L) 240 205 110 123
Albumin (g/
dL)
2.2 1.5 2.1 3.5
Histology
Histology IEL
Intact villi
Chronic
inflammation
Intact villi
Duodenum + jejunum+ illeum:
lymphoplastic infiltrate
Colon + cecum + rectum:
lymphoplastic infiltrate
IEL
Subtotal villous atrophy
IEL
Subtotal villous atrophy Segmental areas normal
Immuno-
phenotype
not obtained Jejunum + illeum: CD3
+CD5
+CD8
+CD7
-preponderance
Jejunum: Polyclonal abTCR
+CD3
+ preponderance
CD8
+CD25
-CD7
- (70% of total
IEL)
Jejunum: Polyclonal abTCR
+CD3
+ (94% of total IEL)
CD8
+CD25
-CD7
- (41% of CD3
+ fraction)
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+). Biopsies samples from the stomach and
esophagus were normal, as was colonoscopy. There was
no evidence of reduced numbers or abnormal morphol-
ogy of epithelial or goblet cells.
Because of the marked IEL without laboratory or his-
tologic evidence of celiac disease, she was treated with
Ciprofloxicin
® and Metronidazole
® for potential bowel
overgrowth and/or tropical sprue. However, six months
of antibiotic therapy did not result in clinical or histolo-
gic improvement (Table 1: 21 months). Although refrac-
tory celiac disease is possible in this scenario, but the
lack of elevated intra-epithelial gδ T-cells, normal TTG
IgA, and her negative HLA-DQ2/DQ9 genotype make
this unlikely. A diagnosis of an immune mediated
enteropathy was therefore considered based on the lack
of clinical or histologic response to dietary and antibio-
tic therapy, and the lack of celiac disease serologic mar-
kers. Prednisone (60 mg) daily was started.
Steroid therapy resulted in marked improvement with
symptom resolution accompanied by a 20 lb weight
gain. She remained in clinical remission 4 weeks after
therapy when repeat Endoscopy demonstrated persistent
IEL, but a reduction in the CD8
+CD7
- fraction to 41%
of total CD3
+ cells (Table 1: 24 months). Histologically,
regions with normal villi were now interspersed with
abnormal regions (Figures 3 and 4). Her LFTs remained
elevated despite the clinical remission and histologic
improvement. The patient decided against maintenance
therapy with prednisone or azathioprine because she
wanted to get pregnant.
Literature Review
At least 29 cases of AIE have been reported, of which,
26 meet the original diagnostic criteria for AIE [3-9]
(Table 2). Eighty five percent (22/26) had anti-epithelial
cell antibodies (anti-enterocyte (AEA): n = 17 (65%),
anti-goblet cell (AGC): n = 7 (27%), or both: n = 2
(8%)), which were of the IgG class in 76% (13/17) with
AEA and 100% (7/7) with AGC. The remaining four
patients without antibodies had at least one
* 
Figure 1 Duodenal biopsy at presentation demonstrating regions of IEL (large arrow) with normal appearing LP (small arrow) and
interspersed areas of villous blunting (*).
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most frequently reported, but no disorder was strongly
associated with AIE. The majority (69%) had other cir-
culating tissue auto-antibodies, most commonly, ANA
(Table 2).
Fourteen studies detailed the sites of disease, and 9
provided some immuno-phenotypic analysis (Table 3).
T h es m a l lb o w e lw a st h em o s tf r e q u e n t l yi n v o l v e d( 7 9 %
of cases), followed by the colon and stomach. Six (43%)
patients had multiple sites and two had extensive disease
(stomach, small intestinal and colonic disease) (’general-
ized autoimmune gut disorder’)[5,10,11]. Nine patients
(75%) had small bowel IEL at presentation while at least
one case reported concurrent colonic IEL. Complete or
partial clinical response with therapy was associated
with improved IEL in all 8 cases that reported these
findings [5-9,11,12]. The IEL was predominantly T-cells
(CD3
+) in at least three cases, and was furthermore CD8
+ in at least one of these. T-cell (CD3
+) lymphocytosis
was also reported in the lamina propria in four of five
c a s e st h a tp r o v i d e dt h i sd a t a( T a b l e3 ) .O n ec a s e
demonstrated extensive abnormalities in CD4
+ T-cells,
including increased tumor necrosis factor (TNF)a pro-
duction from activated rectal lymphocytes [5]. However,
this finding must be cautiously extrapolated because
that patient had active CMV colitis and it is therefore
possible that the TNFa response represent
epiphenomena.
Discussion
We report a patient with an enteropathy associated
with an aberrant CD8
+CD7
- T-cell IEL. Clinically, on
histology and by flow cytometry, our patient had char-
acteristic features of an immune mediated enteropathy.
The abberant T-cell subset in our patient was reprodu-
cible, polyclonal, and correlated with the presence of
clinical symptoms. Moreover, the symptom resolution
and weight gain with steroid therapy correlated with
improvement in villous architecture and a decrease in
the CD8
+CD7
- T-cell subset. These facts strongly
Figure 2 Duodenal biopsy before steroid therapy demonstrating regions with persistent IEL (large arrow) with marked LP
lymphocytosis (small arrow).
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involved in our patient’s enteropathy and was poten-
tially causative, especially considering the failure of
dietary exclusion, antibiotics and other therapies in
inducing clinical, histologic or immunologic improve-
ment. The salient feature of our case therefore remains
the aberrant CD8
+CD7
- IEL in the absence of abnorm-
alities in CD4
+ or NK cells as have been previously
reported in AIE [5,13].
CD7 is a member of the immuno-globulin superfamily
and is expressed on most thymocytes and early in the
ontogeny of T- and NK-cells where it is thought to par-
ticipate in intracellular signaling [14]. The majority of
peripheral T-cells in adults bear CD7, but CD7
- T-cells
are a normally circulating minority comprising 9% of all
peripheral blood monocytes (PMBC). The majority of
CD7
- T-cells are CD4
+ (8% of PMBC) with CD8
+CD7
-
cells accounting for the remaining 1% of PMBC (CD4
+/CD8
+ ratio = 8)[15]. Although the exact function of
CD7
- T-cells is uncertain, they appear to be terminally
differentiated, activated T-cells. Stimulated CD4
+CD7
-
T-cells produce high levels of interleukin-2 and gamma
interferon, and compared with CD7
+ subsets, have aug-
mented proliferative responses to protein antigens [15].
Furthermore, CD7
- T-cells express higher levels of acti-
vation markers including CD45RO and CD25 compared
with their CD7
+ counterparts [15]. CD7
- T-cells may
also play a role in autoimmune disease evidenced by the
increased CD4
+CD7
- cell expansion and accumulation
reported in rheumatoid arthritis [16] and psoriasis [17].
T h e s ed a t as u g g e s tt h a tt h eC D 8
+CD7
- subset demon-
strable in our patient were activated cells that were
potentially causative.
The diagnosis of AIE requires the presence of auto-
immune phenomena, typically taken to be circulating
auto-antibodies to intestinal epithelial cells and/or the
presence of auto-immune disease(s) in the absence of
celiac disease or PIDs. Our patient had no evidence of
anti-epithelial cell antibodies, and in the absence of her
diagnosis of AIH, had no other auto-immune condi-
tions. Moreover, her diagnosis of AIH, although based
on accepted guidelines, is suspect as she had “auto-
* 
Figure 3 Duodenal biopsy 4 weeks after completing steroid therapy obtained during symptom resolution demonstrating normal
tissue (IEL and LP compartments marked by large and small arrows, respectively).
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liver biopsy [2]. Notably the classical AIE criteria remain
controversial, with alternative suggestions to limit the
AIE to only those with demonstrable anti-gut epithelial
cell antibodies or refine the diagnosis based on histolo-
gic immuno-phenotypic characteristics [5]. Regardless of
whether our patient meet criteria for AIE, the cumula-
tive evidence suggest our patient had an immune
mediated enteropathy. This conclusion is further bol-
stered by the reduced fraction of CD8
+CD7
- cells con-
current with clinical improvement on prednisone
therapy.
Our review finds that AIE is most often characterized
by (a) IgG subclass anti-epithelial cell antibodies, (b)
preferential small bowel Involvement, and (c) CD3
+ ab
TCR
+ intra-epithelial and lamina propria lympocytosis.
A protean set of histologic abnormalities have been
reported, including: villous atrophy, absence of goblet
and paneth cells [3,4,18], IEL and infiltrates into the
lamina propria (LP). The clinical features and
therapeutic response of those with AIE but without
anti-epithelial cell antibodies [4,10,19,20] appears indis-
tinguishable to those with antibodies. While the data
suggest AIE is associated with a CD3
+ T-cell intra-
epithelial and lamina propria lymphocytosis, it must be
judiciously interpreted due to the paucity of cases that
reported immuno-phenotypic findings, and because CD3
+ cells are the dominant subtypes in these compart-
ments. CD4
+ T cells are thought to be at least partially
responsible for AIE based on (a) the phenotypic similari-
ties between AIE and the IPEX syndrome [21,22], (b)
t h er o l eo fC D 4
+ T cells in villous atrophy [23] and (c)
the aberrant CD4
+ T cell subsets and CD4
+ IEL
reported in some cases of AIE [5]. Despite these points,
our review suggests that, at present, there is insufficient
evidence to definitively confirm or refute this hypothesis
in adult onset AIE. It also remains possible that AIE is
the common phenotypic result of a heterogeneous set of
mechanistic abnormalities rather than a single unified
condition.
* 
Figure 4 Duodenal biopsy obtained at the same time as in figure 3, but from a different region demonstrating abnormal tissue with
blunted architecture (IEL and LP compartments marked by large and small arrows, respectively).
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Reference Gender,
Age
Anti-Enterocyte
antibodies
Anti-
Goblet cell
antibodies
Auto-antibodies Auto-immune
involvement
Immune abnormalities
16 F, 38 IgA and IgG NR - NR NR
16 F, 47 IgA and IgG NR Anti-actin
Anti-parietal
Anti-thyroid microsomal
NR NR
8 F, 39 + NR Anti-thyroid microsomal Anti-
thyroglobulin
ITP
Raynaud
Hepatitis
Cholangitis
Impaired antibody production to mitogens and protein
antigens
19 F, 50 IgG NR - Perivisceritis
Food allergies
NR
18 F, 82 IgG NR NR NR NR
20 M, 67 NR NR NR NR NR
20 F, 39 NR NR NR NR NR
22 F, 58 - NR Anti-parietal cell
ANCA
Anti-thyroglobulin
Anti-thyroid peroxidase
T- and B-cell pulmonary
infiltrate
Autoimmune thyroiditis
Sicca syndrome
Polyneuropathy
Pancreatitis (possible)
Autoimmune neutropenia
CD4
+ lymphopenia
Granulocytopenia
15 M, 54 + NR pANCA
ANA
NR NR
3 M, 19 - IgG NR Collagenous enterocolitis
Elevated liver enzymes
Elevated pancreatic
enzymes
Atopic dermatitis
Uveitis
Hyperthyroidism
NR
17 F, 35 IgA and IgG NR Anti-CCP
ANA
Rheumatoid arthritis NR
21 M, 59 NR NR Anti-intrinsic factor Pangastritis (atrophic) NR
4M , 2 1 N R N R R F
ANA
Autoimmune hemolytic
anemia
Hypothyroidism
Raynaud
Exfoliative dermatitis
Elevated IgG
Low IgA
24 M, 58 + NR Anti-parietal cell
Anti-thyroid globulin
Anti-thyroid peroxidase
Anti-adrenal cortical
NR NR
23 M, 37 IgG - ANA Pancreatic insufficiency NR
B
i
s
h
u
e
t
a
l
.
B
M
C
G
a
s
t
r
o
e
n
t
e
r
o
l
o
g
y
2
0
1
1
,
1
1
:
1
3
1
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
3
0
X
/
1
1
/
1
3
1
P
a
g
e
7
o
f
1
0Table 2 Reported Cases and Auto-Antibodies (Continued)
23 M, 75 IgG IgG Anti-acetylcholine receptor
Anti-striated muscle
Anti-glutamic acid dehydrogenase
Myasthenia gravis
Thymoma
Autoimmune myopathy
Autoimmune
gastroenterocolitis
NR
23 F, 46 - IgG - Psoriatic arthritis NR
23 F, 42 - IgG - Atopic dermatitis
Autoimmune
gastroenterocolitis
NR
23 F, 38 - IgG Anti-parietal cell Pancreatic insufficiency
Autoimmune
gastroenterocolitis
NR
23 F, 76 IgG - ANA NR hypogammaglobulinemia (low IgG and low IgM)
23 M, 55 - - - NR CVID
23 M, 40 IgM - ANA NR CVID
23 M, 54 - IgG - NR CVID
23 M, 67 IgA and IgG - - NR Polyclonal hypergammaglobulinemia
23 F, 45 IgG IgG Anti-SSA
Anti-phospholipid
Sjogren’s
RA
Raynauds
Refractory sprue
Lymphocytic colitis
NR
23 M, 59 IgG - ANA Autoimmune
gastroenterocolitis
NR
23 M, 75 NR NR Anti-saccharomyces cerevisiae
antibodies
Autoimmune
gastroenterocolotis
Polyclonal hypergammaglobulinemia
23 F, 61 IgG - pANCA
ANA
Hypothyroidism
Refractory sprue
NR
23 F, 59 IgG - ANA Lymphocytic colitis
Hypothyroidism
NR
Abbreviations:
ANA: anti-nuclear antibody
ANCA: anti-neutrophil cytoplasmic antibody (p: protoplasmic)
Anti-CCP: anti-cyclic citrullinated peptide antibody
CVID: common variable immune deficiency
ITP: idiopathic thrombocytopenic purpura
RF: rheumatoid factor
NR: not reported
B
i
s
h
u
e
t
a
l
.
B
M
C
G
a
s
t
r
o
e
n
t
e
r
o
l
o
g
y
2
0
1
1
,
1
1
:
1
3
1
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
3
0
X
/
1
1
/
1
3
1
P
a
g
e
8
o
f
1
0Conclusions
Our patient likely had an auto-immune enteropathy
associated with an aberrant CD8+CD7- T-cell IEL. Our
review of adult onset AIE suggest that the most com-
mon features are the presence of IgG type anti-gut
epithelial antibodies and preferential small bowel
involvement.
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